Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 30: 1304-1309, 1984;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, T. W.
Right arrow Articles by Powers, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, T. W.
Right arrow Articles by Powers, D. M.

Clinical Chemistry, Vol 30, 1304-1309, Copyright © 1984 by American Association for Clinical Chemistry

The Ektachem clinical chemistry slide for simultaneous determination of unconjugated and sugar-conjugated bilirubin

TW Wu, GM Dappen, RW Spayd, MW Sundberg and DM Powers

Using dual-wavelength spectrometry, we have refined the mordant-based bilirubin slide method (Clin Chem 28:2366-2372, 1982) to co-detect unconjugated bilirubin (Bu) and its sugar conjugates (Bc) in 10 microL of serum. The assay is based on three principles: (a) mono- and diconjugated bilirubins behave spectrally like one fraction (Bc) when bound to the mordant, (b) Bu and Bc are spectrally distinct, and (c) B delta (the bilirubin-albumin complex) is not measured in the film. With known bilirubin mixtures, results by the assay agree with those by nuclear magnetic resonance, by a Jendrassik-Grof method for total bilirubin, and by a liquid-chromatographic procedure. With patients' sera, the slide correlates with a liquid-chromatography-augmented Jendrassik-Grof method, according to the following typical regression statistics (in mumol/L): for Bu, slope = 0.992, r = 0.996, intercept = - 0.376, Sy X x = 5.08; for Bc, slope = 0.970, r = 0.985, intercept = - 0.735, Sy X x = 8.16. The method is precise (for Bu, CV = 5.2% at an average concentration of 16.4 mumol/L, and 4.1% at 66.7 mumol/L; for Bc, CV = 6.5% at 23.4 mumol/L, and 3.8% at 151.7 mumol/L for pools of patients' sera), is relatively interference free, and has potential for extension to further applications.


The following articles in journals at HighWire Press have cited this article:


Home page
PediatricsHome page
K. L. Yeo, M. Perlman, Y. Hao, and P. Mullaney
Outcomes of Extremely Premature Infants Related to Their Peak Serum Bilirubin Concentrations and Exposure to Phototherapy
Pediatrics, December 1, 1998; 102(6): 1426 - 1431.
[Abstract] [Full Text] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
J. C. ARGYLE and J. C. RUTLEDGE
Bilirubin Subfractions
Arch Pediatr Adolesc Med, July 1, 1988; 142(7): 700 - 700.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Association for Clinical Chemistry.